IDG Capital is a venture capital and private equity investment firm focused on funding technology companies across early to growth stages. It blends global perspective with deep local expertise in China and Asia, mobilizing international resources to support inbound and outbound opportunities. Headquartered in Hong Kong and established in 1993, the firm has built one of the first institutional investment platforms in China and maintains relationships with influential business leaders. It works with private equity and venture capital fund managers, investment advisors, and entities worldwide, managing funds in USD and RMB and backing portfolio companies with a long-term value approach, particularly in software, information technology, and related sectors.

Morningside Group is a venture capital firm founded in 1986, originally established as a family office for the Chan family, and is based in the greater Boston area. The firm makes venture investments in companies with novel science and technology, pursuing a long-term, patient approach to company-building and emphasizing ethical practices. Its investment focus spans life sciences, digital health, artificial intelligence, materials science, and information technology. In addition to its investment activities, Morningside supports charitable initiatives in education, research, and healthcare, with partnerships including the Harvard T.H. Chan School of Public Health, UMass Chan Medical School, and the MIT Morningside Academy for Design.

SDIC Innovation Investment Management is the private equity and venture capital arm of State Development & Investment Corp. It makes investments across technology and manufacturing sectors, including mobile internet, internet of things, cloud computing, big data, information technology services, industrial robotics, and intelligent manufacturing. The firm also targets high-end medical equipment, diagnostics, high-value consumables, modern agricultural equipment, ships and marine engineering, new materials, clean energy, energy conservation, and healthcare; for new energy vehicles it focuses on intelligent upstream and downstream supply chains, power batteries and systems, and related technologies. Founded in 2009, the company is based in Beijing with an additional office in Asia. The firm aims to support development and deployment of innovative technologies through private equity and venture capital investments.

Hiway Capital is a venture capital firm based in Guangzhou, China. Established in 2007, it focuses on investments across manufacturing, healthcare, new materials and energy, agriculture, and enterprise services.

Qiming Venture Partners is a China-based venture capital firm founded in 2006, with offices in Shanghai, Beijing, Suzhou, Hong Kong and Singapore. It backs early and growth-stage technology, consumer and healthcare companies, applying deep industry knowledge and hands-on support to help portfolio companies scale. The firm manages US-dollar and RMB funds and maintains a global footprint, including a dedicated US arm, Qiming Venture Partners USA, to pursue cross-border opportunities in healthcare, therapeutics and digital health. Since inception, it has invested in more than 530 companies and achieved more than 200 exits via IPOs, M&A or other means, with over 70 portfolio companies reaching unicorn or super unicorn status. Qiming emphasizes long-term partnerships with entrepreneurs, aligning resources and networks to drive innovation and societal progress across its portfolio.

Shenzhen Capital Group is a government-backed venture capital and private equity firm based in Shenzhen, established in 1999. It concentrates on early-stage and growth investments in information technology, internet, new media, biopharma, new energy, environmental protection, advanced materials, high-end equipment manufacturing, and consumer sectors, with a focus on SMEs and enterprises in emerging industries. The firm seeks long-term value creation through active portfolio development, including post-investment services that support growth and commercialization. Beyond direct investments, it manages broader capitalization activities such as mutual funds, real estate funds, and asset securitization. Shenzhen Capital Group has built a large, diversified portfolio and has supported numerous companies through to initial public offerings in domestic and international markets.

WI Harper Group is a cross-border venture capital firm with offices in Beijing, Taipei, and San Francisco. Founded in 1993, it focuses on early and early expansion investments across the United States, Greater China, and the Asia Pacific, with a history of backing technology, healthcare, clean technology, and related sectors. The firm pursues a global-local approach, providing financing, strategic guidance, and partnerships to help startups through early growth toward exits such as IPOs or acquisitions.

Legend Capital is a Beijing-based venture capital firm and the investment arm of Legend Holdings, founded in 2001 to back high-growth technology and related companies in China and markets connected to China. The firm concentrates on early-stage IT, telecommunications, media, healthcare, consumer services, modern services, and sectors such as infrastructure, clean technology, and advanced manufacturing. It provides portfolio companies with strategic resources, market access support, and tailored services to help with business development, branding, and navigating the Chinese market, aiming to create value and maximize returns for investors.

Shunwei Capital is a Beijing-based venture capital firm founded in 2011 that focuses on early- to growth-stage investments in China's internet and technology sectors. The firm emphasizes opportunities in the local internet industry and technology, including software, hardware, smart devices, and related areas such as new media, games, internet finance, and rural internet, with selective cross-border activity in East Asia. It manages multiple funds and pursues incubation, startups, and growth capital investments. Notable portfolio companies include Xiaomi, Huami, iQiyi, and Viomi Technology, reflecting the firm's emphasis on leading technology-enabled consumer and IoT businesses. Shunwei supports founders through capital and operational experience to help scale ideas into global companies.

ZhenFund is a Beijing-based venture capital firm founded in 2011 by Bob Xu and Victor Wang in collaboration with Sequoia Capital China. It specializes in early-stage investments across technology-driven sectors including AI, e-commerce, education, fintech, life sciences, autonomous driving, and healthcare. The firm has built a broad network of more than 800 portfolio companies, including numerous unicorns, and supports entrepreneurs with mentorship and resources such as demo days, ZhenHR services, marketing and PR guidance, and fundraising assistance. Its active CEO network facilitates peer support via platforms like WeChat. ZhenFund also runs entrepreneur-focused initiatives such as ZhenSummer Grant, ZhenResidence, and ZhenCampus, aiming to foster innovation and practical market impact. The firm emphasizes founder quality and market need, seeking startups with ambitious goals and a hands-on approach to growth.

Y&R Capital is a Beijing-based venture capital firm and high-tech incubator established in 2015 that concentrates on medical health, artificial intelligence and robotics, and intelligent manufacturing; it funds precision medicine initiatives and related technologies and also offers incubation and service management to portfolio companies.

Matrix Partners is a venture capital firm founded in 1977 and based in San Francisco that funds early-stage technology companies. The firm focuses on applied AI, B2B software, fintech, health tech, infrastructure and hardware, and supports ventures from idea to Series A with a hands-on, founder-friendly approach drawn from its team of former entrepreneurs. It has backed and partnered with companies such as Apple, FedEx, Oculus, Canva, Zendesk and HubSpot, Postmates and Fivetran, illustrating a history of broad technology investments across the United States, China and India. Matrix Partners combines local knowledge with global experience to help portfolio companies scale into category-leading businesses.

SOSV is a global venture capital firm headquartered in Princeton, New Jersey, focused on seed-to-growth investments in deep tech, life sciences, hardware and software, with a strong emphasis on human and planetary health. The company operates startup development programs such as HAX and IndieBio, offering facilities, labs, engineering resources, mentorship, and collaborative workspaces to help founders advance technology and accelerate fundraising. Beyond capital, SOSV provides hands-on support to accelerate product development, customer acquisition and scaling, connecting portfolio companies with a global network of partners and investors. Its ecosystem spans multiple regions and markets, including cross-border ventures in Asia, and it maintains a portfolio of startups that have progressed to subsequent funding rounds. In addition to direct investments, SOSV’s programs and resources are designed to help early-stage companies mature toward scalable, sustainable growth while fostering innovation across sectors that address health, climate, and technology challenges.

Panda Capital is a China-based venture capital firm founded in 2015 that focuses on early-stage investments, from angel to Series B, in technology-driven startups. It aims to be a primary or early institutional investor for fast-growing companies in data-driven AI applications, enterprise services, fintech, logistics, mobility and transportation, and emerging consumer trends. Based in Shanghai, the firm seeks to support founders through initial growth stages and has backed a range of innovative ventures in the Chinese tech ecosystem.

GGV Capital is a global venture capital firm that, as of March 2024, operates as two distinct brands: Granite Asia, headquartered in Singapore, investing in the APAC region including Southeast Asia, Japan, China, India and Australia; and Notable Capital, based in Silicon Valley with offices in San Francisco and New York, investing in the United States, Israel, Europe and Latin America. The firm backs early- and growth-stage technology companies and leverages an international network to help portfolio companies scale across borders.

Kinzon (Shenzhen) Investment Management is a venture capital firm founded in 2016 that focuses on early‑stage and growth investments in leading‑edge technology, innovative consumption, and education sectors. The firm operates secondary funds and maintains offices in Beijing, Shanghai, and Shenzhen.

IMM Investment is a Seoul-based independent private equity and venture capital firm established in 1999. The company engages in mezzanine and growth investments and pursues opportunities in mergers and acquisitions, venture capital, corporate restructuring, private equity, industry consolidation, management buyouts, spin-offs, recapitalizations, and cross-border transactions. It concentrates on medium-sized companies operating in information technology infrastructure, wireless communications, software, contents, and other technology-enabled sectors, with a particular emphasis on information technology, healthcare/biotech, and manufacturing. The firm typically takes an active role in governance and strategic direction and focuses on opportunities within South Korea and cross-border contexts. IMM Investment aims to support portfolio companies through growth, expansion, and consolidation, leveraging its long-standing relationships with institutional investors and investment professionals.

Bright Venture Capital is a venture capital firm headquartered in Shenzhen, China. It focuses on early- and middle-stage investments across technology-related sectors, including information technology, internet, cloud computing and advanced manufacturing, and seeks opportunities in adjacent areas such as media, telecommunications, culture and media, healthcare education, entertainment consumer, and new retail. The firm pursues investments in both private equity in the primary market and secondary stock opportunities.

Glory Ventures is a Shanghai-based venture capital firm that backs early- and growth-stage startups, with a cross-border focus on China and Israel. The firm concentrates on consumer market opportunities and sectors including intelligent hardware, IoT, AI, and computer vision, and also pursues B2B enterprise services, consumption upgrade, and related tech subsectors. It pursues a research-driven approach and seeks to create industrial ecosystems by integrating private equity resources and public-listed company assets to offer value-added support and strategic synergies. Exits are considered through mergers and acquisitions and initial public offerings. Glory Ventures operates with a global perspective, actively investing in Israel and China and aiming to connect startups with established industrial players to accelerate adoption of deep-tech solutions. Through its ecosystem-building activities, Glory Ventures has cultivated relationships with notable investors and corporates and maintains a portfolio across AI, IoT, fintech, and related fields.

F&G Venture is a venture capital firm established in September 2012 by a former rotating CEO of Huawei and a partner of Fidelity Asia. It focuses on investments in companies experiencing exponential growth in information technology sectors, including IT infrastructure, cloud computing, Internet of Things, SaaS, big data, microchips, and semiconductors, and also targets high-end manufacturing businesses such as modules, intelligent devices and equipment, robots, and drones.

Sequoia Capital China is a venture capital firm founded in September 2005, headquartered in Beijing, with additional offices in Hong Kong and Shanghai. The firm specializes in a wide range of investments across various stages, including seed, start-up, early, mid, late, and growth stages. Its investment focus spans multiple sectors, including consumer services, technology, healthcare, financial services, and energy. Key areas of investment include agriculture, education, industrial technology, clean technology, blockchain, and advanced manufacturing. Sequoia Capital China aims to support innovations in medical health, consumer goods, logistics, and artificial intelligence, among others. The firm typically invests between $100,000 and $1 million in seed companies, $1 million to $10 million in early-stage ventures, and $10 million to $50 million in growth investments. As a subsidiary of Sequoia Capital, it leverages a broad network and expertise to foster the development of promising businesses primarily within China.

Northern Light Venture Capital is a China-focused venture capital firm founded in 2005 that concentrates on early and growth-stage technology opportunities. It targets information technology, TMT, clean technologies, healthcare, consumer services, and related sectors, aiming to back enterprises that leverage China's industrial and human resources strengths. The firm has raised multiple funds, including RMB and US dollar vehicles, and has invested in more than 180 portfolio companies. Notable early investments include Meituan.com, Kaixin001.com, Gogo.com, redbaby.com, MasaMaso.com, and Velo City, reflecting a focus on technology-enabled businesses across China with global potential. The management team combines local industry executives and returnee professionals with broad investing and entrepreneurial experience, supporting portfolio companies through scale and internationalization.

Vertex Ventures is a global network of operator-investors that supports technology startups by pairing operating experience with access to capital, talent, partners and customers to help build globally scalable businesses. With activities across the United States, China, Israel, India and Southeast Asia, the firm provides hands-on support to portfolio companies, leveraging its ecosystem to help startups grow from early stages to global markets. The group emphasizes collaboration with founders and industry partners, active portfolio involvement, and a deep focus on software, data, security, healthcare and other technology sectors.

Lightspeed Venture Partners is a global venture capital firm based in Menlo Park, California, with additional offices in Beijing, Shanghai, New Delhi, and Herzliya. Founded in 2000, the firm backs companies across seed, early, and growth stages, investing in software, enterprise technology, consumer internet, fintech, healthtech, and cleantech sectors. It provides equity and debt financing and seeks opportunities globally, including the United States, Asia, and Israel. Lightspeed partners with entrepreneurs to scale businesses from inception through expansion, supporting a broad range of sectors such as AI, mobile, e-commerce, data infrastructure, and security. The firm emphasizes long-term partnerships and hands-on involvement to help portfolio companies navigate growth and market dynamics.

Source Code Capital is a Beijing-based venture capital firm founded in 2014 that invests in Chinese technology companies across early and growth stages. It focuses on the TMT sector and the firm's core drivers Internet+, AI+ and Global+, backing companies across finance, media and entertainment, consumer services, enterprise, retail, transportation, housing, education and healthcare. The firm manages substantial capital, including about $1.5 billion and RMB 3.5 billion, and concentrates its investments in China. Through a post-investment platform it offers mentorship, resources and global perspectives to support founders. Its portfolio includes notable Chinese tech firms such as ByteDance, Meituan and Homelink, reflecting a hands-on approach to help founders scale.

5Y Capital is a China-based private equity and venture capital firm specializing in seed, start-up, early venture, and growth capital investments. It backs entrepreneurs across healthcare, life sciences, technology, fintech, internet, information services, consumer and business services, media, education, digital health, and medical devices, with a focus on China and Asia-Pacific markets. Founded in 2008 in Shanghai by Ken Shi and Richard Liu, the firm operates as part of the Morningside Group and maintains offices in Shanghai, Beijing and Hong Kong. Its investor base includes sovereign wealth funds, endowments, foundations, family offices and funds of funds. By supporting portfolio companies with capital and strategic guidance, it helps them scale and expand domestically and regionally.

Xianghe Capital is a venture capital firm focusing on early and growth-stage investments in China’s TMT sector. Founded by Hesong Tang and Maggie Yang, former Baidu corporate development executives, the firm leverages strategic analysis and deep industry connections to identify and support transformative opportunities. The founders’ backgrounds include leadership in landmark deals in China’s internet landscape, such as iQiyi, Qunar, PPS and 91 Wireless, and experience across Baidu, other leading internet companies and VC funds.

Lighthouse Capital Management is a venture capital firm based in Shanghai, founded in 2011. It specializes in early-stage investments in hardware equipment, the internet, and enterprise data services, with activity in both China and the United States. It has invested in more than 40 companies domestically and overseas.

DCM Ventures is a venture capital firm founded in 1996 and based in Menlo Park, California, with offices in Silicon Valley, Beijing and Tokyo. It invests across software, consumer, enterprise, health tech, fintech and deep tech sectors, targeting opportunities in the United States, China and Japan. The firm manages funds totaling about $4 billion and has backed more than 400 technology companies, providing hands-on operational guidance and access to a global network of partners to support portfolio growth.

Gaorong Capital is a Beijing-headquartered venture capital firm that targets early-stage technology investments in the Asia-Pacific region, with interests spanning telecommunications, media, life sciences, cosmetics, and other technology sectors.

GSR Ventures is a venture capital firm focused on early-stage technology companies, including AI-enabled enterprise software, consumer platforms, and digital health and medical technology. The firm backs entrepreneurs pursuing disruptive businesses with the potential to dominate multi-billion dollar markets. Founded in 2004 and based in Menlo Park, California, it operates in the United States and China, supporting early-stage companies from inception through growth.

JAFCO is a Tokyo-based venture capital and investment firm founded in 1973 as Japan Associated Finance. It has backed entrepreneurs across Japan, Asia and the United States, participating in venture and buyout investments and supporting portfolio companies with HR, marketing, sales and back-office operations, in addition to providing financing. The firm has a long track record, with over 1,000 portfolio IPOs and capital commitments exceeding 1 trillion yen. Its investment approach spans seed to growth stages, including technology, IT, SaaS, healthcare, consumer services, and related sectors, aiming to help portfolio companies scale through strategic partnerships and an extensive regional and international network.

Eight Roads Ventures is a global venture capital firm and the corporate venture capital arm of Fidelity International, with offices in the United Kingdom, China, India, Japan, and the United States. It manages substantial assets and has a 50-year track record of investing in technology, healthcare, fintech, and related sectors, building a portfolio of more than 500 companies including Alibaba, AppsFlyer, Chewy, and Toast. The firm supports startups across early and growth stages, often taking minority stakes and seeking board representation, and leverages Fidelity's resources to help portfolio companies scale. Eight Roads operates through regional platforms such as Eight Roads China and regional Europe and Asia funds, with a focus on SaaS, enterprise software, IT, fintech, consumer tech, and health tech across Asia, Europe, and beyond. Associated funds, including F-Prime Capital, complement its investment program. The firm emphasizes long-term partnerships and global reach to back innovative ventures that improve products, operations, and growth trajectories.

CDH Investments is an international alternative asset manager based in Beijing with offices in Hong Kong. Established in 2002, it runs a diversified platform across private equity, venture capital, growth, real assets, mezzanine, public equities, and wealth management, focusing on Greater China. The firm invests across stages from early to middle-market buyouts, targeting consumer, hard technology, new energy, and healthcare sectors, as well as related areas such as information technology, media, finance, and manufacturing. With experienced investment teams that have collaborated for years, CDH seeks to generate value through its China-focused approach, managing over $27 billion in assets.

Baidu Ventures is the corporate venture capital arm of Baidu that backs technology startups primarily in artificial intelligence and related fields. It pursues opportunities in AI, autonomous driving, robotics, big data, life sciences, and other technology sectors, supporting entrepreneurs from its offices in Beijing and San Francisco. The firm aims to help portfolio companies accelerate development and scale by leveraging Baidu's technical expertise and industry resources, reflecting Baidu's interest in advancing the next generation of AI-enabled products and services.

Based in Seoul, Korea Investment Partners is a leading venture capital and private equity firm with a global footprint, including offices in Shanghai, Beijing, and Sunnyvale. With over 30 years of investment experience, it provides capital and growth funding to bold entrepreneurs across technology, media, healthcare, and manufacturing, backing notable companies such as Kakao, Naver, YG Entertainment, Osstem Implant, Bodyfriend, DoubleU Games, and Didi Chuxing. The firm manages multiple funds with assets under management in the billions and operates a global network to support portfolio companies from early to growth stages. It is a subsidiary of Korea Investment Holdings, aligning client interests with governance and long-term value creation.

OrbiMed is a global healthcare investment firm founded in 1989 and based in New York, with a worldwide presence that includes offices in several regions. It allocates capital across private equity, venture capital, and public equity to support healthcare companies at various stages, from startups to established firms. Its focus spans biopharmaceuticals, medical devices, diagnostics, life sciences tools, and digital health, as well as healthcare services. The firm pursues opportunities across major markets in North America, Europe, and Asia, often leveraging region-specific teams to invest in companies in Israel, China, India, South Korea, and other jurisdictions. OrbiMed emphasizes building world-class companies by providing strategic financing, industry expertise, and global resources to portfolio companies in pursuit of medical breakthroughs and sustainable growth.

Sunsino Venture Group is a Taipei-based venture capital firm established in the early 1990s that invests in healthcare, technology and software companies. It has backed more than 200 companies in Taiwan and the United States, and reports assets under management of about US$150 million.

K2VC is a Beijing-based venture capital firm focused on angel and early-stage investments in technology-driven startups in China. Founded in 2010, it backs ventures in internet, e-commerce, mobile internet, fintech, and other technology sectors, emphasizing technology upgrades, innovative business models, and changes in consumer lifestyles. The firm supports early-stage companies across areas such as advanced manufacturing, new energy, industrial digitalization, healthcare, and consumer technology to accelerate growth and innovation in the Chinese market.

Oriental Fortune Capital is a Shenzhen-based venture capital firm that invests in seed to Pre-IPO opportunities across China. The firm backs early to growth-stage companies in information technology, semiconductors, big data, telecom, media and entertainment, biomedicine and healthcare, energy and environmental technology, new materials, advanced manufacturing, consumer goods, and related services. It concentrates on investments in key Chinese markets, with operations in Shenzhen and offices in Shanghai, Beijing and Wuhu, and focuses on the Pearl River Delta, Yangtze River Delta, and Circum-Bohai-Sea regions including major cities such as Shenzhen, Guangzhou, Shanghai, Nanjing, Tianjin and Beijing. Portfolio strategy emphasizes allocations of roughly 20% to early stage, 40% to expansion, and 40% to Pre-IPO opportunities. The firm seeks to identify innovative, growth-oriented technology and modern service companies that can scale domestically and regionally within China.

China Growth Capital is a Beijing-based venture capital firm founded in 2006 that supports seed to Series B rounds, focusing on early-stage and growth investments. It operates primarily in China with extended links to Silicon Valley and manages RMB and USD funds. Typical investments range from 1 to 5 million per company, with a hard cap of 15 million per deal, and the firm backs companies across fintech, enterprise software and services, SaaS, online education, consumer internet, frontier technology, life sciences, and marketplace platforms, aiming to back scalable businesses with global growth potential.

Global Brain is a Tokyo-based venture capital firm established in 1998 that invests in technology companies from seed to pre-IPO stages and operates across Europe, North America, Africa and Asia-Pacific. The firm backs startups in sectors such as artificial intelligence, blockchain, cloud and software-as-a-service, cybersecurity, advertisement, agritech, foodtech, climate technology, and commerce, among others, and emphasizes hands-on support and resources to portfolio companies. It manages pure investment funds as well as corporate venture funds formed with leading public companies, enabling strategic collaboration and broader networks. Over its history, Global Brain has invested in hundreds of startups and facilitated numerous exits including IPOs and mergers and acquisitions, underscoring its active role in building early-stage technology companies.

SBI Investment is the corporate venture capital arm of SBI Holdings, based in Tokyo. It makes venture capital and growth investments across information technology, fintech, artificial intelligence, blockchain, cybersecurity, e-commerce, biotechnology and life sciences, healthcare, energy and environmental sectors, with a regional focus on China, Southeast Asia and Korea. It backs seed and growth-stage companies and aims to exit through IPOs and M&A, while also managing venture funds to support business development and the growth of core industries in the 21st century.

BlueRun Ventures is a global venture capital firm founded in 1998 and headquartered in San Mateo, California, with offices in the United States, Shanghai, Beijing, and Korea. It invests in technology companies across fintech, digital health, enterprise software, consumer experiences, and mobile opportunities, spanning the United States and Asia. The firm has backed influential startups and exits, including PayPal, Waze, and Topsy, demonstrating a history of supporting market-leading platforms. BlueRun Ventures positions itself as a partner to founders, leveraging a global network to identify opportunities and help scale businesses across its core sectors.

Sequoia Capital is a venture capital firm founded in 1972 and based in Menlo Park, California. It finances startups across seed, early, and growth stages, with a focus on technology-driven sectors such as information technology, internet, software, mobile, and telecommunications, as well as healthcare, energy, financial services, and related industries. The firm supports ambitious founders through capital allocation and guidance, aiming to help build durable companies that reach IPOs or acquisitions. Sequoia operates globally with investments in the United States and international markets, often engaging across multiple rounds and collaborating with portfolio companies throughout their growth lifecycle. The firm emphasizes long-term partnerships, rigorous due diligence, and a hands-on approach to scaling operations, product development, and go-to-market strategies.

Oriza Holdings is a Suzhou-based investment holding company and asset manager in China. Through multiple investment arms, it conducts equity and debt investments, venture and growth financing, and fund-of-funds activities, aiming to connect investment resources with industrial capabilities. The group manages substantial assets and supports innovation by fostering platforms that integrate capital with technology and entrepreneurship. It backs startups and growth-stage companies across information technology, healthcare, biotechnology, artificial intelligence, semiconductors, cloud computing, big data, and other TMT sectors, with a focus on the China region and Southeast Asia. The firm emphasizes early-stage to mature investments and collaborates with industry and academic partners to promote regional economic development, including initiatives such as regional innovation competitions and talent development programs. By aligning capital with strategic sectors, Oriza Holdings seeks to enhance value across its portfolio while contributing to China's innovation ecosystem.

Eli Lilly and Company is a global pharmaceutical company engaged in discovery, development, manufacture, and sale of medicines. It operates with facilities in the United States, Puerto Rico, and numerous other countries, and its products are sold in about 135 countries. The company conducts research to address human diseases and also pursues animal health research and products to support animal health and agricultural production. Lilly emphasizes patient support, safety, and quality manufacturing, and pursues ongoing innovation in areas such as neuroscience, cardiometabolic disease, cancer, and immunology to bring new therapies to patients worldwide.

Plum Ventures is a venture capital firm based in China that concentrates on seed and early-stage investments. It backs technology, new media, telecommunications, consumer-focused businesses, and related sectors such as hardware, the new economy, and internet finance. The firm typically invests in rounds ranging from RMB 2 million to RMB 30 million. Founded in 2014, Plum Ventures supports early-stage companies across China, helping them scale and innovate in fast-changing markets.

Vision Plus Capital, also known as Yuan Jing Capital, is a venture capital firm founded in 2015 and based in Hangzhou, China, with additional offices in Beijing, Shanghai and Hong Kong. The firm focuses on early-stage investments across internet and healthcare technology sectors, including internet innovation, digital health, intelligent technology, AI, enterprise services, consumer internet and related areas, and seeks to support startups with practical experience in talent recruitment, strategic planning, operational upgrading and financing strategies. Vision Plus Capital targets opportunities in China, including cross-border RMB and dollar investments, and backs ventures that leverage data analytics, AI and digital infrastructure to drive enterprise digitization and enhanced consumer services.

Zoy Capital is a venture capital firm founded in 2013 and based in Beijing, China, with offices in Shanghai, Shenzhen, and Suzhou, focusing on equity investments in artificial intelligence, service robots, and modern media.